Johnson & Johnson (JNJ) has declared a quarterly dividend of $1.30 per share, reinforcing its commitment to returning value to shareholders. The dividend is payable to shareholders of record on December 8, 2025, with an ex-dividend date set for November 24, 2025. Investors must own shares prior to this date to be eligible for the payment.
With a dividend yield of 2.79%, this announcement highlights Johnson & Johnson's ongoing efforts to provide regular income to its investors. The company, which operates in the pharmaceuticals and medical devices sectors, continues to demonstrate a strong cash flow generation capability, a critical factor for income-focused investors.
As of November 8, 2025, Johnson & Johnson reports a market capitalization of $449.7 billion and a price-to-earnings (P/E) ratio of 17.90. Upcoming earnings are anticipated on July 13, 2026, with an estimated EPS of $2.92 and revenue expectations of $25.0 billion. This financial stability underpins the company's ability to maintain its dividend policy, although dividends are not guaranteed and can be adjusted based on company performance.
Investors should consider the company's dividend history and overall financial health when evaluating the sustainability of these payments.